Table 1: Association of variables between group A (removal of antibiotic bone cement spacer) and group B (not removal).
|
|
Group A (n = 19) |
Group B (n = 8) |
P-value |
|
|
Male |
6 |
3 |
> 0.999 |
|
|
Female |
13 |
5 |
||
|
Age |
60.79 ± 9.20 |
66.25 ± 7.36 |
0.089 |
|
|
DM |
11 (57.9%) |
1 (12.5%) |
0.043 |
|
|
Location |
Metatarsophalangeal joint |
8 |
1 |
0.105 |
|
Ankle |
3 |
3 |
||
|
Calcaneus |
4 |
1 |
||
|
Midfoot |
0 |
2 |
||
|
Toe |
4 |
1 |
||
|
ESR(mm/h) |
Pre-op |
45.95 ± 32.98 |
37.25 ± 26.41 |
0.595 |
|
Follow up |
19.58 ± 19.63 |
28.00 ± 18.29 |
0.159 |
|
|
CRP(mm/h) |
Pre-op |
27.12 ± 50.95 |
36.69 ± 83.40 |
0.541 |
|
Follow up |
7.51 ± 18.34 |
6.16 ± 11.95 |
0.441 |
|
|
WBC count (×103 cells/μl) |
Pre-op |
8.10 ± 2.52 |
7.78 ± 3.19 |
0.595 |
|
Follow up |
6.38 ± 1.46 |
6.18 ± 1.65 |
0.937 |
|
|
Duration of administration of antibiotic (weeks) |
4.79 ± 2.37 |
4.13 ± 2.03 |
0.517 |
|
|
Complications |
5(26.3%) |
2 (25.0%) |
> 0.999 |
|